MedCity News October 28, 2020
Elise Reuter

Instead of suggesting a diagnosis for moles and skin lesions, digital health startup Miiskin is leaving that up to dermatologists. The company is rolling out a version of its tool for clinicians to make it easier for their patients to track moles and other spots on their skin.

While a swath of skin startups tout AI tools to help people identify bumps, moles and rashes, Danish startup Miiskin is building its business around dermatologists.

The company has designed an app to help users track spots and moles over time, but does not provide an automated diagnosis. Instead, it provides regular reminders for users to check their skin and lets them compare photos over time. It also has a mapping feature...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, Patient / Consumer, Physician, Provider, Technology
Ozempic And Other Weight Loss Drugs Will Only Work With Digital Health
‘Investors Are Hungry To Find the Best’: It’s Feast or Famine in Digital Behavioral Health Investing
Delivering the Right Approach for Virtual Primary Care: 3 Key Insights
Q&A: Bring your own device: How patients own tech is being used in clinical trials
How can pharma speed time to treatment? Digital tools can help

Share This Article